Keio University

Published papers

Matsushita, Maiko

21-37 items (total 37)

A Novel Phthalimide Derivative, TC11, Has Preclinical Effects on High-Risk Myeloma Cells and Osteoclasts.

Author
Matsushita Maiko, Ozaki Y, Hasegawa Y, Terada F, Tabata N, Shiheido H, Yanagawa H, Oikawa T, Matsuo K, Du W, Yamada T, Hozumi M, Ichikawa D, Hattori Y.
Publication Title
Magazine name PLoS One Volume 10(Issue 1) Start Page e0116135 (Publication Date)2015/01)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
With

Codon 72 Polymorphism of TP53 Gene Is a Novel Prognostic Marker for Thalidomide Therapy in Multiple Myeloma.

Author
Hattori Y, Ikeda Y, Suzuki Y, Ichikawa D, Matsushita M.
Publication Title
Magazine name British Journal of Haematology Volume 165(Issue 5) Start Page 728 - End Page 731 (Publication Date)2014/01)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
With

Detection of leukemia associated antigen-specific cytotoxic T cells in a patient with Philadelphia chromosome-positive leukemia during treatment with dasatinib.

Author
Matsushita M, Tonegawa K, Mori T, Kohashi S, Kato J, Matsuki E, Okamoto S, Hattori Y.
Publication Title
Magazine name Leukemia Lymphoma Volume 55(Issue 3) Start Page 722 - End Page 724 (Publication Date)2013/06)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
With

A Myeloma Cell Line Established from a Patient Refractory to Thalidomide Therapy Revealed High-Risk Cytogenetic Abnormalities and Produced Vascular Endothelial Growth Factor.

Author
Hattori Y, Du W, Yamada T, Ichikawa D, Matsunami S, Matsushita M.
Publication Title
Magazine name Blood Cancer J Start Page e115 (Publication Date)2013/05)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
With

Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI(3)kinase/AKT/Bcl-X(L) Activation and CD8(+) T Cell-mediated Tumor Eradication.

Author
Zhong XS, Matsushita M*, Plotkin J, Riviere I, Sadelain M.
Publication Title
Magazine name Mol Ther Start Page 413-20 (Publication Date)2010/02)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
With

Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts.

Author
Brentjens RJ, Santos E, Nikhamin Y, Yeh R, Matsushita M*, La Perle K, Quintás-Cardama A, Larson SM, Sadelain M.
Publication Title
Magazine name Clin Cancer Res Start Page 5426-5435 (Publication Date)2007/09)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
With

Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.

Author
Matsushita M*, Yamazaki R, Ikeda H, Mori T, Sumimoto H, Fujita T, Okamoto S, Ikeda Y, Kawakami Y.
Publication Title
Magazine name Br J Haematol Start Page 56-65 (Publication Date)2006/01)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
With

Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer.

Author
Ito K, Fujita T, Akada M, Kiniwa Y, Tsukamoto M, Yamamoto A, Matsuzaki Y, Matsushita M, Asano T, Nakashima J, Tachibana M, Hayakawa M, Ikeda H, Murai M, Kawakami Y
Publication Title
Magazine name International Journal of Cancer Volume 108(Issue 5) Start Page 712-724 (Publication Date)2004)
Authorship Category
Single Work
Publication Category
Research paper (scientific journal)
Peer-review Status
Without

Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer.

Author
Ito K, Fujita T, Akada M, Kiniwa Y, Tsukamoto M, Yamamoto A, Matsuzaki Y, Matsushita M*, Asano T, Nakashima J, Tachibana M, Hayakawa M, Ikeda H, Murai M, Kawakami Y.
Publication Title
Magazine name Int J Cancer Start Page 712-724 (Publication Date)2004/02)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
With

Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.

Author
Ikeda H, Matsushita M, Waisfisz Q, Kinoshita A, Oostra AB, Nieuwint AW, De Winter JP, Hoatlin ME, Kawai Y, Sasaki MS, D'Andrea AD, Kawakami Y, Joenje H.
Publication Title
Magazine name Cancer Research Volume 63(Issue 10) Start Page 2688-2694 (Publication Date)2003)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
With

Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies.

Author
Matsushita M*, Yamazaki R, Ikeda H, Kawakami Y.
Publication Title
Magazine name Leuk Lymphoma Start Page 439-44 (Publication Date)2003/03)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
With

1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).

Author
Muto A, Kizaki M, Yamato K, Kawai Y, Kamata-Matsushita M, Ueno H, Ohguchi M, Nishihara T, Koeffler HP, Ikeda Y
Publication Title
Magazine name Blood Volume 93(Issue 7) Start Page 2225-2233 (Publication Date)1999)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
With

造血器腫瘍におけるPRAME

Author
Ikeda Hideyuki, Matsushita Maiko, Kawakami Yutaka
Publication Title
Volume 39(Issue 1) Start Page 46-50 (Publication Date)1999)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
Without

PRAME protein expressed in leukemia cells as a target molecule for immunotherapy.

Author
池田英之,松下麻衣子,河上裕
Publication Title
Magazine name Rinsho Ketsueki Volume 40(Issue 6) Start Page 484-486 (Publication Date)1999)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
Without

造血器腫瘍における腫瘍抗原と免疫療法

Author
Matsushita Maiko, Ikeda Hideyuki, Kawakami Yutaka
Publication Title
Volume 31(Issue 5) Start Page 1155-1160 (Publication Date)1999/05)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
Without

造血器腫瘍における腫瘍抗原と免疫療法

Author
Matsushita Maiko, Ikeda Hideyuki, Kawakami Yutaka
Publication Title
Volume 31(Issue 5) Start Page 1155-1160 (Publication Date)1999/05)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
Without

新しくクローニングされた癌特異抗原―PRAME

Author
Ikeda Hideyuki, Matsushita Maiko
Publication Title
Volume 42(Issue 7) Start Page 811-813 (Publication Date)1998/07)
Authorship Category
Joint Work
Publication Category
Research paper (scientific journal)
Peer-review Status
Without